Catgut Implantation at Acupoints has an Immunosuppressive Effect on Autoimmune Uveitis by Regulating Th1/Th17 Lymphocytes

IF 0.2 4区 医学 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Acupuncture & Electro-Therapeutics Research Pub Date : 2021-01-01 DOI:10.3727/036012921x16237619666012
Feifei Chen, Jianying Zhao, Shuyang Zhong, Fengming Zheng, Xiaobo Hao
{"title":"Catgut Implantation at Acupoints has an Immunosuppressive Effect on Autoimmune Uveitis by Regulating Th1/Th17 Lymphocytes","authors":"Feifei Chen, Jianying Zhao, Shuyang Zhong, Fengming Zheng, Xiaobo Hao","doi":"10.3727/036012921x16237619666012","DOIUrl":null,"url":null,"abstract":"Catgut implantation at acupoints (CIA) has a long history as a medical treatment for a wide variety of diseases, including autoimmune diseases. However, the effect and mechanism of this therapy in autoimmune uveitis is still largely unknown. The aim of this study was to explore the immunity-inhibitory effect of CIA in an experimental autoimmune uveitis (EAU) rat model. EAU was established in Lewis rats by the injection of IRBP1177–1191 peptide. The rats were randomly divided into control and CIA groups. Phenotypic and histological assessments were performed days 9, 13, 18, 23 post-immunization. The percentage of Th1 and Th17 lymphocytes isolated from lymph nodes were determined by flow cytometry. The expression of IL-17 and IFN-γ was detected by real-time quantitative PCR and enzyme-linked immunosorbent assay (ELISA). In the CIA group, delayed mild inflammation was observed. Pathological investigation found alleviated infiltration of lymphocytes and ocular damage. Flow cytometry showed significantly decreased Th17 lymphocytes at day 9, 13, and 18 post-immunization (P<0.05) and no significant changes at day 23 post-immunization (P=0.868) after CIA. The Th1 lymphocytes were significantly decreased at day 13 and 18 post-immunization (P<0.05) and comparable at day 9 (P=0.111) and 23 (P=0.551) post-immunization in the CIA group. IL-17 and IFN-γ mRNA levels were notably decreased at day 9, 13 and 18 post-immunization (P<0.05) and showed a downward trend at day 23 post-immunization, although with no significance (P=0.080 and P=0.137, respectively) after CIA. Serum IL-17 and IFN-γ levels in the CIA group were significantly decreased at day 9, 13 and 18 post-immunization (P<0.05) and were comparable at day 23 post-immunization (P=0.078 and P=0.979, respectively). Ocular inflammation was markedly inhibited after catgut implantation at Pishu (BL20) and Shenshu (BL23) acupoints in an EAU rat model. Moreover, CIA reduced Th1 and Th17 lymphocytes and the expression IFN-γ and IL-17.","PeriodicalId":50881,"journal":{"name":"Acupuncture & Electro-Therapeutics Research","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acupuncture & Electro-Therapeutics Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3727/036012921x16237619666012","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Catgut implantation at acupoints (CIA) has a long history as a medical treatment for a wide variety of diseases, including autoimmune diseases. However, the effect and mechanism of this therapy in autoimmune uveitis is still largely unknown. The aim of this study was to explore the immunity-inhibitory effect of CIA in an experimental autoimmune uveitis (EAU) rat model. EAU was established in Lewis rats by the injection of IRBP1177–1191 peptide. The rats were randomly divided into control and CIA groups. Phenotypic and histological assessments were performed days 9, 13, 18, 23 post-immunization. The percentage of Th1 and Th17 lymphocytes isolated from lymph nodes were determined by flow cytometry. The expression of IL-17 and IFN-γ was detected by real-time quantitative PCR and enzyme-linked immunosorbent assay (ELISA). In the CIA group, delayed mild inflammation was observed. Pathological investigation found alleviated infiltration of lymphocytes and ocular damage. Flow cytometry showed significantly decreased Th17 lymphocytes at day 9, 13, and 18 post-immunization (P<0.05) and no significant changes at day 23 post-immunization (P=0.868) after CIA. The Th1 lymphocytes were significantly decreased at day 13 and 18 post-immunization (P<0.05) and comparable at day 9 (P=0.111) and 23 (P=0.551) post-immunization in the CIA group. IL-17 and IFN-γ mRNA levels were notably decreased at day 9, 13 and 18 post-immunization (P<0.05) and showed a downward trend at day 23 post-immunization, although with no significance (P=0.080 and P=0.137, respectively) after CIA. Serum IL-17 and IFN-γ levels in the CIA group were significantly decreased at day 9, 13 and 18 post-immunization (P<0.05) and were comparable at day 23 post-immunization (P=0.078 and P=0.979, respectively). Ocular inflammation was markedly inhibited after catgut implantation at Pishu (BL20) and Shenshu (BL23) acupoints in an EAU rat model. Moreover, CIA reduced Th1 and Th17 lymphocytes and the expression IFN-γ and IL-17.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
穴位埋线通过调节Th1/Th17淋巴细胞对自身免疫性葡萄膜炎的免疫抑制作用
穴位植入(CIA)作为一种治疗多种疾病的医学方法有着悠久的历史,包括自身免疫性疾病。然而,这种疗法在自身免疫性葡萄膜炎中的作用和机制在很大程度上仍然未知。本研究旨在探讨CIA在实验性自身免疫性葡萄膜炎(EAU)大鼠模型中的免疫抑制作用。通过注射IRBP1177-1191肽在Lewis大鼠中建立EAU。将大鼠随机分为对照组和CIA组。免疫后第9、13、18、23天进行表型和组织学评价。采用流式细胞术检测淋巴结中Th1和Th17淋巴细胞的百分比。采用实时定量PCR和酶联免疫吸附法(ELISA)检测IL-17和IFN-γ的表达。CIA组出现迟发性轻度炎症。病理检查发现淋巴细胞浸润减轻,眼部损伤减轻。流式细胞术显示免疫后第9天、第13天、第18天Th17淋巴细胞明显减少(P<0.05),免疫后第23天无显著变化(P=0.868)。CIA组免疫后第13天、第18天Th1淋巴细胞显著降低(P<0.05),免疫后第9天(P=0.111)、第23天(P=0.551) Th1淋巴细胞显著降低。IL-17和IFN-γ mRNA水平在免疫后第9天、第13天和第18天显著降低(P<0.05),在免疫后第23天呈下降趋势,但CIA后差异无统计学意义(P=0.080和P=0.137)。CIA组血清IL-17和IFN-γ水平在免疫后第9、13和18天显著降低(P<0.05),在免疫后第23天具有可比性(P=0.078和P=0.979)。在EAU大鼠模型脾俞穴(BL20)和肾俞穴(BL23)植入术后,眼部炎症明显受到抑制。此外,CIA降低了Th1和Th17淋巴细胞以及IFN-γ和IL-17的表达。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acupuncture & Electro-Therapeutics Research
Acupuncture & Electro-Therapeutics Research 医学-全科医学与补充医学
CiteScore
0.50
自引率
66.70%
发文量
9
审稿时长
>12 weeks
期刊介绍: The aim of the journal is to provide an international forum for the exchange of ideas and promotion of basic and clinical research in acupuncture, electro-therapeutics, and related fields. The journal was established in order to make acupuncture and electro-therapeutics a universally acceptable branch of medicine through multidisciplinary research based on scientific disciplines. The final goal is to provide a better understanding of both the beneficial and adverse effects of these treatments in order to supplement or improve existing methods of diagnosis, prognosis, treatment, and prevention of diseases in both Western and Oriental medicine.
期刊最新文献
Clinical Study of Opposing Needling Combined With Eye Acupuncture Therapy for Treatment of Muscle Spasm in Post-stroke Hemiplegia Patients Therapy for Treatment of Muscle Spasm in Post-Stroke Hemiplegia Patients Effect of Acupuncture on the Serum and Local Microcirculatory Biochemical Parameters in Phantom Limb Pain Catgut Implantation at Acupoints has an Immunosuppressive Effect on Autoimmune Uveitis by Reducing Th1/Th17 Lymphocytes Discussion on the Theoretical Basis for Acupuncture to Improve Knee Osteoarthritis from "Intestinal Microecology" Influence of Electroacupuncture on Acupoints of Yanglingquan (GB34) on Gallbladder Volume and Gallbladder Arterial Hemodynamics in Patients With Chronic Cholecystitis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1